Literature DB >> 9727984

Control of antimicrobial resistance: time for action. The essentials of control are already well known.

P Huovinen, O Cars.   

Abstract

Mesh：

Substances：

Year:  1998        PMID： 9727984      PMCID： PMC1113829          DOI： 10.1136/bmj.317.7159.613

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  9 in total

1.  Changes in reimbursement policy for antibiotics and prescribing patterns in general practice.

Authors:  Flemming Hald Steffensen; Henrik C. Schønheyder; Jens Tølbøll Mortensen; Kirsten Nielsen; Henrik Toft Sørensen
Journal:  Clin Microbiol Infect       Date:  1997-02       Impact factor: 8.067

2.  The effect of changes in the consumption of macrolide antibiotics on erythromycin resistance in group A streptococci in Finland. Finnish Study Group for Antimicrobial Resistance.

Authors:  H Seppälä; T Klaukka; J Vuopio-Varkila; A Muotiala; H Helenius; K Lager; P Huovinen
Journal:  N Engl J Med       Date:  1997-08-14       Impact factor: 91.245

3.  Preventing the emergence of antimicrobial resistance. A call for action by clinicians, public health officials, and patients.

Authors:  B Schwartz; D M Bell; J M Hughes
Journal:  JAMA       Date:  1997-09-17       Impact factor: 56.272

Review 4.  Antimicrobials for acute otitis media? A review from the International Primary Care Network.

Authors:  J Froom; L Culpepper; M Jacobs; R A DeMelker; L A Green; L van Buchem; P Grob; T Heeren
Journal:  BMJ       Date:  1997-07-12

5.  Society for Healthcare Epidemiology of America and Infectious Diseases Society of America Joint Committee on the Prevention of Antimicrobial Resistance: guidelines for the prevention of antimicrobial resistance in hospitals.

Authors:  D M Shlaes; D N Gerding; J F John; W A Craig; D L Bornstein; R A Duncan; M R Eckman; W E Farrer; W H Greene; V Lorian; S Levy; J E McGowan; S M Paul; J Ruskin; F C Tenover; C Watanakunakorn
Journal:  Infect Control Hosp Epidemiol       Date:  1997-04       Impact factor: 3.254

Review 6.  Effect of antimicrobial use and other risk factors on antimicrobial resistance in pneumococci.

Authors:  K G Kristinsson
Journal:  Microb Drug Resist       Date:  1997       Impact factor: 3.431

7.  Influence of patients' expectations on antibiotic management of acute lower respiratory tract illness in general practice: questionnaire study.

Authors:  J Macfarlane; W Holmes; R Macfarlane; N Britten
Journal:  BMJ       Date:  1997-11-08

8.  Limiting the spread of penicillin-resistant Streptococcus pneumoniae: experiences from the South Swedish Pneumococcal Intervention Project.

Authors:  K Ekdahl; H B Hansson; S Mölstad; M Söderström; M Walder; K Persson
Journal:  Microb Drug Resist       Date:  1998       Impact factor: 3.431

9.  Comparative efficacy of alternative hand-washing agents in reducing nosocomial infections in intensive care units.

Authors:  B N Doebbeling; G L Stanley; C T Sheetz; M A Pfaller; A K Houston; L Annis; N Li; R P Wenzel
Journal:  N Engl J Med       Date:  1992-07-09       Impact factor: 91.245
  9 in total
  14 in total

Review 1.  Infection and antimicrobial prescribing control in the new millennium: nightmare or nirvana?

Authors:  B Cookson
Journal:  J Clin Pathol       Date:  2000-01       Impact factor: 3.411

2.  Antibiotic resistance: the Bermuda experience.

Authors:  S Smith; R C Tilton
Journal:  J Clin Microbiol       Date:  1999-04       Impact factor: 5.948

3.  Bacteriotherapy: the time has come.

Authors:  P Huovinen
Journal:  BMJ       Date:  2001-08-18

4.  Risk factors for fluoroquinolone resistance in Gram-negative bacilli causing healthcare-acquired urinary tract infections.

Authors:  P Rattanaumpawan; P Tolomeo; W B Bilker; N O Fishman; E Lautenbach
Journal:  J Hosp Infect       Date:  2010-12       Impact factor: 3.926

5.  Antibacterial prescribing and antibacterial resistance in English general practice: cross sectional study.

Authors:  P Priest; P Yudkin; C McNulty; D Mant
Journal:  BMJ       Date:  2001-11-03

6.  Management of urinary tract infection in general practice: a cost-effectiveness analysis.

Authors:  E A Fenwick; A H Briggs; C I Hawke
Journal:  Br J Gen Pract       Date:  2000-08       Impact factor: 5.386

7.  Antimicrobial susceptibilities of 1,684 Streptococcus pneumoniae and 2,039 Streptococcus pyogenes isolates and their ecological relationships: results of a 1-year (1998-1999) multicenter surveillance study in Spain.

Authors:  E Pérez-Trallero; C Fernández-Mazarrasa; C García-Rey; E Bouza; L Aguilar; J García-de-Lomas; F Baquero
Journal:  Antimicrob Agents Chemother       Date:  2001-12       Impact factor: 5.191

8.  C-reactive protein measurement in general practice may lead to lower antibiotic prescribing for sinusitis.

Authors:  Lars Bjerrum; Bente Gahrn-Hansen; Anders P Munck
Journal:  Br J Gen Pract       Date:  2004-09       Impact factor: 5.386

9.  Update on the clinical utility and optimal use of cefditoren.

Authors:  José Barberán; Lorenzo Aguilar; María-José Giménez
Journal:  Int J Gen Med       Date:  2012-05-21

Review 10.  Cefditoren in upper and lower community-acquired respiratory tract infections.

Authors:  Francisco Soriano; María-José Giménez; Lorenzo Aguilar
Journal:  Drug Des Devel Ther       Date:  2011-02-09       Impact factor: 4.162
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.